Publicado 4 números por año
ISSN Imprimir: 0893-9675
ISSN En Línea: 2162-6448
Indexed in
Preface: Targeting the Human Kinome for Cancer Therapy
SINOPSIS
-
Hudis CA. , Trastuzumab--mechanism of action and use in clinical practice.
-
Sullivan C, Peng C, Chen Y, Li D, Li S. , Targeted therapy of chronic myeloid leukemia.
-
Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. , The protein kinase complement of the human genome.
-
Pao W, Chmielecki J. , Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer.
-
Fu Chuan, Zheng Xueyun, Jiang Yao, Liu Yan, Xu Pengxiang, Zeng Zhiping, Liu Rihe, Zhao Yufen, A universal and multiplex kinase assay using γ-[18O4]-ATP, Chemical Communications, 49, 27, 2013. Crossref
-
Kathiriya Jaymin J., Pathak Ravi Ramesh, Clayman Eric, Xue Bin, Uversky Vladimir N., Davé Vrushank, Presence and utility of intrinsically disordered regions in kinases, Mol. BioSyst., 10, 11, 2014. Crossref
-
Liu Yu-Ching, Tsai Fuu-Jen, Chen Chao-Jung, A rapid, multiplexed kinase activity assay using 8-plex iTRAQ labeling, SPE, and MALDI-TOF/TOF MS, The Analyst, 145, 3, 2020. Crossref
-
Brown-Clay Joshua D., Shenoy Deepika N., Timofeeva Olga, Kallakury Bhaskar V., Nandi Asit K., Banerjee Partha P., PBK/TOPK enhances aggressive phenotype in prostate cancer via β-catenin-TCF/LEF-mediated matrix metalloproteinases production and invasion, Oncotarget, 6, 17, 2015. Crossref